CXCL12 and neoplasm: Following treatments, anti-SDF1 antibody significantly inhibited Wnt1 tumor growth, and the average tumor size of control anti-GD treated group (n = 10) was 1,266 mm3 where as anti-SDF1 treated group was 674 mm3 (p = 0.029; Fig. 4A).